|New Threads Only:|
|New Threads & Replies:|
Forum List » Guru News and Commentaries|
Guru News, Stock picks and commentaries
Weekly CEO Buys Highlight: OPK
Posted by: GuruFocus (IP Logged)
Date: January 6, 2014 03:45PM
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:
Opko Health Inc. (OPK): CEO and Chairman, 10% Owner Phillip Frost Md Et Al Bought 210,900 Shares
CEO & Chairman, 10% Owner of Opko Health Inc. (OPK) Phillip Frost Md Et Al bought 210,900 shares during the past week at an average price of $8.58. Opko Health Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health Inc. has a market cap of $3.5 billion; its shares were traded at around $8.58 with and P/S ratio of 30.30.
Opko Health recently reported its third quarter 2013 financial results. Net loss for the three months ended Sept. 30, 2013, was $60.0 million, compared to a net loss of $10.2 million for the 2012 period. The increase in net loss for the three months ended Sept. 30, 2013, was primarily related to increased operating and clinical trial activities.
George Soros bought 745,000 shares in the quarter that ended on 09/30/2013, which is 0.072% of the $9.14 billion portfolio of Soros Fund Management LLC. Mario Gabelli owns 15,000 shares as of 09/30/2013, which accounts for 0.0008% of the $17.03 billion portfolio of GAMCO Investors.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
Guru Discussed: George Soros: Current Portfolio, Stock Picks
Stocks Discussed: OPK,
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.